Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics.

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics. BMC Cancer. 2013 Feb 27; 13:93.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.